| Touro University Medical Group | |
|
1805 N California St Ste 201 Stockton CA 95204-6032 | |
| (209) 645-4005 | |
| (209) 645-6344 |
| Full Name | Touro University Medical Group |
|---|---|
| Speciality | Internal Medicine |
| Location | 1805 N California St Ste 201, Stockton, California |
| Authorized Official Name and Position | Richard Brian Riemer (VICE-PRESIDENT) |
| Authorized Official Contact | 2096454005 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Touro University Medical Group 1805 N California St Ste 201 Stockton CA 95204-6032 Ph: (209) 645-4005 | Touro University Medical Group 1805 N California St Ste 201 Stockton CA 95204-6032 Ph: (209) 645-4005 |
| NPI Number | 1215573613 |
|---|---|
| Provider Enumeration Date | 11/20/2019 |
| Last Update Date | 05/22/2023 |
| Medicare PECOS PAC ID | 5799119541 |
|---|---|
| Medicare Enrollment ID | O20200306000111 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215573613 | NPI | - | NPPES |
| Provider Name | Shaista Rauf |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1336227073 PECOS PAC ID: 8921040601 Enrollment ID: I20050523001302 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Richard B Riemer |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1962509067 PECOS PAC ID: 2961430376 Enrollment ID: I20050727000947 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Rohini J Joshi |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1538190806 PECOS PAC ID: 7012938327 Enrollment ID: I20051214000830 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Zeba Vanek |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1043233869 PECOS PAC ID: 8820146814 Enrollment ID: I20090430000475 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Trilok Singh Puniani |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1235231770 PECOS PAC ID: 3971653940 Enrollment ID: I20090612000287 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Paul Hing Ping Lee |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1033298724 PECOS PAC ID: 5890974802 Enrollment ID: I20110124000453 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Priyasheelta Nand |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1174843916 PECOS PAC ID: 6709034523 Enrollment ID: I20120919000382 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Jennifer A Oakes |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1740247428 PECOS PAC ID: 6901705425 Enrollment ID: I20160630001465 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Anil Harrison |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487656567 PECOS PAC ID: 1052435914 Enrollment ID: I20180503001895 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Brett David Cherrington |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1801231261 PECOS PAC ID: 7315253788 Enrollment ID: I20180518001927 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Satveet Khela |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1306378369 PECOS PAC ID: 8022350529 Enrollment ID: I20190502002508 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Stephanie Dong |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1104369198 PECOS PAC ID: 3072844778 Enrollment ID: I20191010002143 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Lawrence E Suess |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669557286 PECOS PAC ID: 5092789206 Enrollment ID: I20200402001512 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Gabriel Mario Moreno |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1376886457 PECOS PAC ID: 1052669967 Enrollment ID: I20200406003123 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Michael Lin Zhang |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1275920977 PECOS PAC ID: 0345671301 Enrollment ID: I20200507002705 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Vijayabharathi Ekambaram |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1093000689 PECOS PAC ID: 6305129552 Enrollment ID: I20201009001341 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Durwood Neal |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1801842539 PECOS PAC ID: 8224135090 Enrollment ID: I20201207000983 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Christine E Skotzko |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1336227669 PECOS PAC ID: 1658468244 Enrollment ID: I20210831002679 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Amanjot K Sidhu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528390804 PECOS PAC ID: 7416127865 Enrollment ID: I20210831002929 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Navneet Kaur |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1013371467 PECOS PAC ID: 4082010962 Enrollment ID: I20210831003104 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Vivek Singh |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1619487105 PECOS PAC ID: 2860899424 Enrollment ID: I20210923002757 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Howard Leslie Feinberg |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194747196 PECOS PAC ID: 0244381499 Enrollment ID: I20211012002996 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Abhishek Shahi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932418118 PECOS PAC ID: 7214163112 Enrollment ID: I20220224002509 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | David Loughran |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1710419486 PECOS PAC ID: 2466791256 Enrollment ID: I20220822000560 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Janie Katherine Lozovski |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1649768227 PECOS PAC ID: 2466703194 Enrollment ID: I20220826002222 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
| Provider Name | Rajbeer S Sangha |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1366754541 PECOS PAC ID: 3072896844 Enrollment ID: I20230919002831 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
Kaiser Health News features an interview with Dr. Robert Ouellet, the immediate past president of the Canadian Medical Association, who "recently participated in a fact-finding mission to five European countries to learn ways to improve the Canadian system. What he found, he said, could also offer lessons for the United States" (Villegas, 9/25).
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
› Verified 5 days ago
James H. Holmes, Jr., M.d., Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1502 St. Mark's Plaza, Suite 5, Stockton, CA 95207 Phone: 209-466-8683 Fax: 209-466-8309 | |
Dameron Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 530 W Acacia St, Stockton, CA 95203 Phone: 209-461-3196 Fax: 209-461-7593 | |
Kulendu G Vasavda Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 221 Tuxedo Court, Suite B, Stockton, CA 95204 Phone: 209-941-0149 Fax: 209-941-2550 | |
Ht Family Physicians, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 77 W March Ln, Suite A, Stockton, CA 95207 Phone: 209-477-5552 Fax: 209-477-5553 | |
San Joaquin County Clinics Chs Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1414 N California St Suite A, Stockton, CA 95202 Phone: 209-953-6400 Fax: 209-468-2321 | |
American Current Care Of California, A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 702 W Hammer Ln, Stockton, CA 95210 Phone: 209-546-7767 Fax: 209-546-7785 | |
Sunny Mann Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2216 N California St Ste A, Stockton, CA 95204 Phone: 209-851-2065 Fax: 209-292-8910 |